commande de lioresal http://www.cricyt.edu.ar/?size=123501&pr... celebrex générique differin venta libre ddavp comprar online venta clomid genérico
buy kamagra in usa viagra oral jelly http://kanab.utah.gov/licence.php?int=26...
nolvadex sur le comptoir http://www.scripts.com/?q=1&prod=&type=2... sildenafil vente
http://crown.kings.edu/?size=599008&pric... viagra pris apotek viagra femme http://www.dril-quip.com/cgi-bin/associa... generische levitra priser viagra
    où acheter viagra france viagra et generique achat viagra par pharmacie belge
    vendo cialis originale viagra naturale indiano vendo viagra barcelona

Tag Archive | "survival"

Pain intensity at presentation is a survival predictor in head and neck cancer

Thursday, October 30, 2014

0 Comments

Source: www.oncologynurseadvisor.com Author: staff Pre-treatment pain intensity is an independent survival predictor for patients with head and neck cancer, according to new research published in The Journal of Pain, the peer-reviewed publication of the American Pain Society. Researchers at M.D. Anderson Cancer Center assessed the extent to which pain severity influences survival in 2,340 newly […]

Continue reading...

Number of immune cells in tumors could soon help predict and treat cancers

Friday, September 26, 2014

0 Comments

Source: www.science20.com Authors: Emma King, University of Southampton and Christian Ottensmeier, University of Southampton Immune cells in the blood primarily defend us against infection. But we’re now learning that these cells can also keep us free from cancer. Patients with less efficient immune systems such as organ transplant recipients or those with untreated HIV, for […]

Continue reading...

Docetaxel regimen tops cisplatin in head and neck cancer

Saturday, July 19, 2014

0 Comments

Source: www.cancernetwork.com Author: Anna Azvolinsky, PhD A phase II study has demonstrated that combining docetaxel-based chemoradiotherapy and the antibody cetuximab postoperatively in patients with high-risk squamous cell carcinoma of the head and neck led to improved disease-free and overall survival, with no unexpected toxicities. The results of the study were published in the Journal of […]

Continue reading...

Chemoradiation offered better survival than accelerated radiation in head and neck squamous cell carcinomas

Wednesday, March 19, 2014

0 Comments

Source: www.oncologypractice.com Author: Neil Osterweil, Oncology Report Digital Network Concurrent chemoradiation offered better overall survival and disease-free survival than accelerated radiotherapy in patients with moderately advanced squamous cell carcinomas of the head and neck, investigators reported at the Multidisciplinary Head and Neck Symposium. Actuarial rates of 2-year overall survival and disease-free survival in patients treated […]

Continue reading...

Study: Oropharyngeal cancer on the rise in young adults

Friday, January 31, 2014

0 Comments

Source: www.sciencecodex.com Author: staff A new study reveals an alarming increase in oropharyngeal cancers among young adults. While the exact cause for this phenomenon is unknown, the human papillomavirus (HPV) may be to blame. According to researchers from Henry Ford Hospital in Detroit there was an overall 60 percent increase from 1973 and 2009 in […]

Continue reading...

Certain genetic alterations may explain head and neck cancer survival disparities

Monday, December 9, 2013

0 Comments

Source: www.sciencecodex.com Author: staff Certain genetic alterations to the PAX gene family may be responsible for survival disparities seen between African-American and non-Latino white men with head and neck cancer, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held […]

Continue reading...

Study reveals genetic diversity within tumors predicts outcome in head and neck cancer

Saturday, May 25, 2013

0 Comments

Source: bionews-tx.com Researchers at the Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear Infirmary have developed a new way to predict the survival rate of patients who have squamous cell carcinoma of the head and neck, thanks to a study partially funded by a CPRIT grant. One of the problems with treating cancer is […]

Continue reading...

Study examines role of DNA, HPV in oral cancer survival

Tuesday, May 14, 2013

0 Comments

Source: www.drbicuspid.com Author: DrBicuspid Staff High-risk types of human papillomavirus (HPV) are increasingly associated with oropharyngeal squamous cell carcinoma (OPSCC). However, HPV-positive OPSCC is highly curable, and patients with HPV have better survival compared with HPV-negative patients, whose cancers are usually associated with alcohol and tobacco use. To better understand the molecular mechanisms underlying these […]

Continue reading...

HPV-positive African-Americans with throat cancer have better outcomes

Monday, April 1, 2013

0 Comments

Source: www.drbicuspid.com Author: DrBicuspid Staff African-Americans with throat cancer who are positive for the human papillomavirus (HPV) have better outcomes than African-Americans without HPV, according to a new study in Clinical Cancer Research (March 26, 2013). African-Americans who are HPV-negative also fared worse than Caucasians both with and without HPV present in oropharyngeal cancer, concluded […]

Continue reading...

The effect of treating institution on outcomes in head and neck cancer

Wednesday, December 12, 2012

0 Comments

Source: medicalxpress.com Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head and Neck Surgery. “Despite similar rates of treatment completion and rate of treatment breaks between groups, […]

Continue reading...